MP265

CAS No. 544-47-8

MP265 ( MP-265; MP 265; S-(4-Chlorobenzyl)Isothiouronium chloride )

Catalog No. M27780 CAS No. 544-47-8

MP265 disrupts the MreB cytoskeleton and has antiproliferative effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 63 Get Quote
25MG 103 Get Quote
50MG 150 Get Quote
100MG 223 Get Quote
500MG 482 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MP265
  • Note
    Research use only, not for human use.
  • Brief Description
    MP265 disrupts the MreB cytoskeleton and has antiproliferative effects.
  • Description
    MP265 disrupts the MreB cytoskeleton and has antiproliferative effects.(In Vitro):In MCF-7 cells, conjugate MP265 showed higher antiproliferative effect than paclitaxel alone. Receptor saturation tests showed that the unconjugated peptide analog of GnRH decreased efficacy of conjugate MP265 in concentration- and time-dependent manner.
  • Synonyms
    MP-265; MP 265; S-(4-Chlorobenzyl)Isothiouronium chloride
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Pin1, Pin4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    544-47-8
  • Formula Weight
    237.1
  • Molecular Formula
    C8H10Cl2N2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.NC(=N)SCc1ccc(Cl)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Uchida T, et al. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol. 2003 Jan;10(1):15-24.
molnova catalog
related products
  • 1-Chloroindan

    1-Chloroindan.Reference standards.

  • D-Galactosamine HCl

    D-Galactosamine HCl?hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice.

  • Labetalone hydrochlo...

    Labetalone hydrochloride is an impurity of Labetalol. Labetalol is an orally active adrenoceptor blocking drug, Labetalol is a competitive antagonist at both alpha- and beta-adrenoceptor sites.